- Home
- CNDT vs ENLV Comparison
CNDT vs ENLV Comparison
Compare CNDT & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNDT | ENLV |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | Israel |
| Employees | 51000 | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.4M | 196.2M |
| IPO Year | 2016 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CNDT | ENLV |
|---|---|---|
| Price | $1.38 | $0.71 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.1M | 363.2K |
| Earning Date | 05-11-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,042,000,000.00 | N/A |
| Revenue This Year | $2.01 | N/A |
| Revenue Next Year | $4.06 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $0.66 |
| 52 Week High | $2.98 | $2.10 |
Technical Indicators
Market Signals| Indicator | CNDT | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 35.94 | 32.13 |
| Support Level | $1.33 | $0.66 |
| Resistance Level | $1.60 | $1.23 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 10.37 | 9.86 |
Price Performance
Historical ComparisonAbout CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.